Alejandro Arana

RTI Health Solutions, Barcelona, Spain

Presentation(s):

• OP-25B - Cardiovascular Risk in Users of Mirabegron Relative to Users of Antimuscarinic Treatments for Overactive Bladder: Findings from a Non-interventional, Real-world Data Safety Study

  Tuesday, August 24, 2021
  1:45 PM – 3:30 PM US Eastern Time

• SP07G - Validation of Acute Outcomes Among Patients with Type 2 Diabetes Mellitus in the Clinical Practice Research Datalink

  Tuesday, August 24, 2021
  3:30 PM – 4:45 PM US Eastern Time